Total Payments
$663.26
2024 Payments
$168.23
Companies
14
Transactions
37
Medicare Patients
2,021
Medicare Billing
$201,261
Payment Breakdown by Category
Food & Beverage$651.75 (98.3%)
Education$11.51 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $651.75 | 36 | 98.3% |
| Education | $11.51 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $197.55 | 12 | $0 (2024) |
| PFIZER INC. | $93.09 | 1 | $0 (2017) |
| ABBVIE INC. | $85.95 | 5 | $0 (2024) |
| Amgen Inc. | $55.25 | 4 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $53.02 | 4 | $0 (2024) |
| Lilly USA, LLC | $43.78 | 3 | $0 (2024) |
| Dexcom, Inc. | $24.56 | 1 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $20.23 | 1 | $0 (2017) |
| FIDIA PHARMA USA INC. | $17.58 | 1 | $0 (2018) |
| Allergan, Inc. | $16.50 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.23 | 9 | Novo Nordisk Inc ($42.84) |
| 2023 | $97.94 | 6 | Novo Nordisk Inc ($42.71) |
| 2022 | $77.17 | 5 | Novo Nordisk Inc ($77.17) |
| 2021 | $55.24 | 4 | Novo Nordisk Inc ($17.34) |
| 2020 | $33.99 | 2 | Novo Nordisk Inc ($17.49) |
| 2019 | $11.27 | 1 | Amgen Inc. ($11.27) |
| 2018 | $46.24 | 3 | Amgen Inc. ($28.66) |
| 2017 | $173.18 | 7 | PFIZER INC. ($93.09) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Respiratory | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.83 | General |
| 11/01/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/25/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 05/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 05/16/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
| 03/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 02/25/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 01/26/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Diabetes | ||||||
| 12/14/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 03/03/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Neuroscience | ||||||
| 01/26/2021 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: Neuroscience | ||||||
| 10/20/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 12 | $1,345 | $461.16 |
| 2022 | 8 | 304 | 414 | $59,558 | $18,578 |
| 2021 | 13 | 884 | 1,617 | $251,956 | $104,499 |
| 2020 | 15 | 821 | 1,403 | $199,509 | $77,723 |
Total Patients
2,021
Total Services
3,446
Medicare Billing
$201,261
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 12 | $1,345 | $461.16 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 179 | $40,633 | $9,778 | 24.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $11,330 | $6,937 | 61.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 25 | $3,975 | $1,257 | 31.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 24 | 26 | $1,248 | $251.76 | 20.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 26 | $1,196 | $250.76 | 21.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 23 | $276.00 | $51.69 | 18.7% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2022 | 11 | 20 | $300.00 | $46.71 | 15.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 14 | 60 | $600.00 | $4.87 | 0.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 264 | 736 | $167,072 | $64,164 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 165 | 165 | $33,990 | $20,879 | 61.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 52 | $16,484 | $6,913 | 41.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 99 | $15,741 | $5,577 | 35.4% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 35 | 35 | $3,675 | $2,325 | 63.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 79 | 80 | $2,160 | $1,259 | 58.3% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 45 | 46 | $1,656 | $941.53 | 56.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 12 | 26 | $2,002 | $778.75 | 38.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 46 | 76 | $3,648 | $737.96 | 20.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 30 | 56 | $2,576 | $572.01 | 22.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 51 | 91 | $1,092 | $202.50 | 18.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 24 | 31 | $620.00 | $135.82 | 21.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 24 | 124 | $1,240 | $13.88 | 1.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 214 | 618 | $124,836 | $44,241 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 160 | 160 | $32,960 | $17,537 | 53.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 106 | $14,522 | $4,887 | 33.7% |
About Dr. Ashley Walker, D.O
Dr. Ashley Walker, D.O is a Family Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2013. The National Provider Identifier (NPI) number assigned to this provider is 1093155111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashley Walker, D.O has received a total of $663.26 in payments from pharmaceutical and medical device companies, with $168.23 received in 2024. These payments were reported across 37 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($651.75).
As a Medicare-enrolled provider, Walker has provided services to 2,021 Medicare beneficiaries, totaling 3,446 services with total Medicare billing of $201,261. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Miami, OK
- Active Since 07/03/2013
- Last Updated 04/05/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1093155111
Products in Payments
- Ozempic (Drug) $101.38
- ELIQUIS (Drug) $93.09
- Rybelsus (Drug) $82.34
- UBRELVY (Drug) $50.81
- QULIPTA (Drug) $40.17
- BEVESPI AEROSPHERE (Drug) $34.30
- MOUNJARO (Drug) $32.67
- Prolia (Biological) $28.66
- Dexcom G6 Transmitter (Medical Supply) $24.56
- CONTRAVE (Drug) $20.23
- AIRSUPRA (Drug) $18.72
- Hymovis (Device) $17.58
- Aimovig (Biological) $15.32
- TRINTELLIX (Drug) $15.13
- Azstarys (Drug) $15.06
- JARDIANCE (Drug) $14.05
- Belviq (Drug) $11.51
- VRAYLAR (Drug) $11.47
- EVENITY (Biological) $11.27
- EMGALITY (Drug) $11.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Miami
Keila Hoover, M.d, M.D
Family Medicine — Payments: $1.1M
Family Medicine $1.1M
Dr. Yamirka Duardo-Guerra, M.d, M.D
Family Medicine — Payments: $1.0M
Family Medicine $1.0M
Ramon Leon, Md, MD
Family Medicine — Payments: $179,798
Family Medicine $179,798
Mirel Sanchez, M.d, M.D
Family Medicine — Payments: $165,828
Family Medicine $165,828
Gilberto Seco, Md, MD
Family Medicine — Payments: $127,612
Family Medicine $127,612
Dr. Clifford Kinder, Md, MD
Family Medicine — Payments: $121,261
Family Medicine $121,261